GSC The List

Post Reply
Forum Home > OEA / OLEOYLETHANOLAMIDE > 2010-2014

[email protected]
Site Owner
Posts: 1174

 

The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900249/?tool=pubmed

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full – 2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed

Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women (full – 2010) http://www.nutritionandmetabolism.com/content/7/1/49

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full – 2010) http://www.jlr.org/content/51/6/1416.full.pdf+html

CD36 gene deletion decreases oleoylethanolamide levels in small intestine of freefeeding mice. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/?tool=pubmed

N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy (full – 2010) http://endo.endojournals.org/content/151/8/3965.full

Endocannabinoids and Human Sperm Cells (link to PDF – 2010) http://www.mdpi.com/1424-8247/3/10/3200

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771

Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19954948

Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-specific role of oleoylethanolamide. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20429051

From surface to nuclear receptors: the endocannabinoid family extends its assets. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20166922

Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136458/?tool=pubmed

Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084524/?tool=pubmed

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111743/?tool=pubmed

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice (full – 2011) http://www.nutritionandmetabolism.com/content/8/1/51

Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21664223

Gut fat sensing in the negative feedback control of energy balance--recent advances. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21557957

The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http://www.jneuroinflammation.com/content/9/1/79

The endocannabinoid system: an overview (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303140/

Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf

The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423238/

Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fearconditioned analgesia and controls fear expression in the presence of nociceptive tone (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/

G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/

Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf

The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572454/

Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. (full – 2012) http://press.endocrine.org/doi/full/10.1210/jc.2011-3018

Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510355/

Stimulating beta cell replication and improving islet graft function by GPR119 agonists. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2011.01332.x/full

Synthesis of oleoylethanolamide using lipase. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22121828

Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22480617

Optimized synthesis and characterization of N-acylethanolamines and Oacylethanolamines, important family of lipid-signalling molecules. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22850591?dopt=Abstract

Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741

Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072521

Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459

Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677644/

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/

Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040

Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice. (full – 2013) http://atvb.ahajournals.org/content/33/2/215.long

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/

The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013) http://www.hindawi.com/journals/ije/2013/259676/

Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20498/full

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain- Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/

Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity. (full – 2013) http://press.endocrine.org/doi/full/10.1210/jc.2012-3390

Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF – 2013) http://www.eurekaselect.com/107948/article

Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain (link to PDF – 2013) http://www.eurekaselect.com/107971/article

Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23340219

Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23398921

Alterations in the endocannabinoid system in the rat valproic acid model of autism. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23643692

Detection of the endocannabinoid metabolome in human plasma and breast milk (abst – 2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad

Quantification of endocannabinoids in postmortem brain of schizophrenic subjects. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614

Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23830028

Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23340219

Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23899642

The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001

Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544

Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24117326

The endocannabinoid system mediates aerobic exercise-induced antinociception in rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24140894

Brain Region-Specific Changes in N-Acylethanolamine Contents with Time of Day. (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12495/abstract

Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128

The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy. (abst – 2013) http://press.endocrine.org/doi/abs/10.1210/jc.2013-2922?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&

Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882055/

Antidepressants and Changes in Concentration of Endocannabinoids and Nacylethanolamines in Rat Brain Structures. (full – 2014) http://download.springer.com/static/pdf/559/art%253A10.1007%252Fs12640-014-9465-0.pdf?auth66=1395868546_998a8d5d87cb02529572689ff9213e4a&ext=.pdf

Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full

Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/

A role for oleoylethanolamide in chronic lymphocytic leukemia (full – 2014) http://www.nature.com/leu/journal/v28/n7/full/leu201410a.html

Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365

Classical endocannabinoid-like compounds and their regulation by nutrients (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570

Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24681513

New players in the fatty acyl ethanolamide metabolism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747663

Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658

Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648

Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101

The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst – 2014) http://www.fasebj.org/content/28/1_Supplement/838.6.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf

September 30, 2014 at 9:19 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.